SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The conversation surrounding the ticker is dominated by intense political polarization and negative sentiment regarding Donald Trump, with traders debating his recent social media posts, foreign policy decisions, and claims about his own history. Discussion is highly fragmented, focusing on themes such as ongoing international conflicts, trade tensions with Canada, and broader concerns about his administrative policies and personal conduct.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Discussion regarding Sellas Life Sciences is dominated by speculation over the timing of the 80th event milestone in the REGAL Phase 3 trial and the associated top-line data release. Traders remain divided between those maintaining high conviction in a potential curative survival benefit for the GPS platform versus those expressing concern over the prolonged timeline, potential trial design issues, and the impact of frequent equity dilution.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending ahead of its upcoming product launch event, with investors closely monitoring rumors regarding a potential new foldable iPhone and the company's broader AI strategy. While some traders are bullish on a pre-event rally, others remain skeptical, citing concerns over production constraints and historical patterns of 'sell-the-news' price drops following product announcements.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CRO is experiencing increased volatility and investor attention amid speculation over potential ETF developments, a new app release, and a significant institutional investment in the underlying exchange. While some market participants express optimism about institutional accumulation and growth, many long-term holders remain skeptical due to concerns over historical token dilution and leadership.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following an upbeat long-term outlook provided by the CFO at the Citi Global TMT Conference, where the company projected its addressable market for AI chips could reach $2 trillion to $3 trillion by 2030. While many traders are optimistic about the firm's accelerated expansion and data center growth, some remain skeptical of the valuation and the sustainability of the recent rally, leading to debate over whether the move is a legitimate breakout or an over-hyped bubble.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is attracting significant attention as traders debate the stock's direction ahead of upcoming earnings, with opinions split between those anticipating a short-term bounce due to oversold conditions and others maintaining a bearish outlook amid concerns over macro-economic pressure on pet spending. Despite the skepticism regarding the stock's long-term performance, many in the community emphasize the company's sticky subscription model and potential for margin expansion through its growing veterinary services.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following the news that Blue Origin was awarded a significant NASA contract, a development that has fueled concerns among some traders about competition and project timelines. While some investors view the current price drop as an overreaction and a buying opportunity, others remain bearish, citing insider share sales and potential Neutron launch delays as reasons for caution.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is gaining significant momentum as investors rotate into nuclear energy stocks, driven by the growing power demands of AI data centers. While some traders are optimistic about the company's technology, others remain cautious due to ongoing concerns about its path to commercialization and lack of new binding contracts.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen shares are trending following the company's Q4 earnings report, which topped revenue and EPS estimates while providing strong guidance for the upcoming year. The discussion is supported by positive community sentiment regarding the growth of its blockbusters and the progress of its MariTide obesity candidate, despite some ongoing focus on drug pricing policies.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Attention is centered on Structure Therapeutics oral GLP-1 obesity program, including upcoming Phase 3 and amylin data catalysts. Traders are also speculating that the company could attract a partnership or buyout from big pharma, although no transaction has been confirmed and some debate the drugs tolerability, liver-safety risks, and competitive positioning.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (Satellos or the Company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today...

Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their...

Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their...

Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to...

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey...

Generation Bio Stock Surged 31% Pre-Market Today – What’s Going On?

Equity

Generation Bio on Tuesday said that it is evaluating strategic alternatives to maximize the value of its assets for shareholders and implementing a strategic restructuring expected to result in a 90% reduction in workforce. 


Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates

Generation Bio (GBIO) delivered earnings and revenue surprises of -11.43% and -51.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of +1.96% and +16.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

Generation Bio Co

Bearish Sentiment

Yes, hike is locked in

No, inflation data still matters more

Fed stays on hold anyway

Too early to tell

August nonfarm payrolls surged by 162,000, nearly triple the 53,000-56,000 consensus estimate and the strongest monthly gain since March, while unemployment held steady at 4.1%, adding fuel to the case for a Federal Reserve rate hike at its September meeting. Does this jobs report cement a September rate hike? Vote and explain your reasoning in the comments.

August nonfarm payrolls surged 162,000, nearly triple estimates, while unemployment held at 4.1%. Does this cement a September rate hike?

Current Price	$5.36
Prev Close	$5.74
Open	$5.63
Dividend Yield	0.00%
50-Day Moving Average	$5.51
Beta	2.00
Avg. Volume	95,297.50
PE Ratio	-0.57

52-Week High	$7.20
52-Week Low	$3.00
Market Capitalization	$35.98M
EPS (Annual)	-$19.76
Price to Book	0.71
Revenue Per Employee	$172,973.91

Feed

News

Sentiment

Earnings

Fundamentals

Info

GBIO Fundamentals